Skip to main content

In vitro activity of daptomycin against clinical isolates ofGram-positive bacteria

Abstract

We determined the activity of daptomycin, a recently FDA-approved antimicrobial agent, against clinical isolates of Gram-positive bacteria, including viridans group streptococci (16 Streptococcus mitis species group, 12 S. mutans species group, 9 S. anginosus species group, 8 S. sanguinis species group, 5 S. salivarius species group) from patients with infective endocarditis, 32 methicillin-resistant Staphylococcus aureus, 32 high-level penicillin-resistant Streptococcus pneumoniae, 38 vancomycin-resistant enterococci (including 1 linezolid-resistant isolate), and thefollowing unusual Gram-positive bacteria: 3 Listeria monocytogenes, 4 Erysipelothrix rhusiopathiae, 9 Corynebacterium species, 10 Abiotrophia/Granulicatella species, 2 Rothia (Stomatococcus) mucilaginosus, and 4 Gemella morbillorum. Daptomycin minimum inhibitory concentration (MIC)90 values for the viridans group streptococci, methicillin-resistant S. aureus, penicillin-resistant S. pneumoniae, and Enterococcus species were 0.5, 0.5, ≤0.125, and 4 µg/ml, respectively. The daptomycin MIC range for the unusual Gram-postitive bacteria was ≤0.125–2 µg/ml. We conclude that daptomycin has in vitro activity against viridans group streptococci associated with endocarditis as well as against several types of unusual Gram-positive bacteria that can cause endocarditis.

This is a preview of subscription content, access via your institution.

References

  1. RR Facklam (2002) ArticleTitleWhat happened to the streptococci: overview of taxonomic and nomenclature changes Clin Microbiol Rev 15 613–30 Occurrence Handle10.1128/CMR.15.4.613-630.2002 Occurrence Handle12364372

    Article  PubMed  Google Scholar 

  2. R Patel JR Uhl P Kohner MK Hopkins FR Cockerill (1997) ArticleTitle3rd. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci J Clin Microbiol 35 703–7 Occurrence Handle9041416

    PubMed  Google Scholar 

  3. Clinical and Laboratory Standards Institute (CLSI). Methodsfor dilution antimicrobial susceptibility tests for bacteria thatgrow aerobically; approved standard. CLSI document M07-A6. Villanova, PA: CLSI; 2003.

  4. GA Pankuch MR Jacobs PC Appelbaum (2003) ArticleTitleBactericidal activityof daptomycin against Streptococcus pneumoniae compared with eight other antimicrobials J Antimicrob Chemother 51 443–6 Occurrence Handle10.1093/jac/dkg091 Occurrence Handle12562720

    Article  PubMed  Google Scholar 

  5. PC Fuchs AL Barry SD Brown (2002) ArticleTitleIn vitro bactericidal activity of daptomycin against staphylococci J Antimicrob Chemother 49 467–70 Occurrence Handle10.1093/jac/49.3.467 Occurrence Handle11864946

    Article  PubMed  Google Scholar 

  6. G Sakoulas GM Eliopoulos J Alder CT Elopoulos (2003) ArticleTitleEfficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 47 1714–8 Occurrence Handle10.1128/AAC.47.5.1714-1718.2003 Occurrence Handle12709345

    Article  PubMed  Google Scholar 

  7. RD Arbeit D Maki FP Tally E Campanaro BI Eisenstein (2004) ArticleTitleThe safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections Clin Infect Dis 38 1673–81 Occurrence Handle10.1086/420818 Occurrence Handle15227611

    Article  PubMed  Google Scholar 

  8. R Patel JM Steckelberg (1997) Infections of the heart JG Murphy (Eds) Mayo Clinic cardiology review Futura Publishing Armonk 555–81

    Google Scholar 

  9. P Brouqui D Raoult (2001) ArticleTitleEndocarditis due to rare and fastidiousbacteria Clin Microbiol Rev 14 177–207 Occurrence Handle10.1128/CMR.14.1.177-207.2001 Occurrence Handle11148009

    Article  PubMed  Google Scholar 

  10. IA Critchley RS Blosser-Middleton ME Jones C Thornsberry DF Sahm JA Karlowsky (2003) ArticleTitleBaseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000–2001 Antimicrob Agents Chemother 47 1689–63 Occurrence Handle10.1128/AAC.47.5.1689-1693.2003 Occurrence Handle12709341

    Article  PubMed  Google Scholar 

  11. A King I Phillips (2001) ArticleTitleThe in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates J Antimicrob Chemother 48 219–23 Occurrence Handle10.1093/jac/48.2.219 Occurrence Handle11481291

    Article  PubMed  Google Scholar 

  12. AL Barry PC Fuchs SD Brown (2001) ArticleTitleIn vitro activities of daptomycin against 2789 clinical isolates from 11 North American medical centers Antimicrob Agents Chemother 46 1919–22 Occurrence Handle10.1128/AAC.45.6.1919-1922.2001

    Article  Google Scholar 

  13. AC Fluit FJ Schmitz J Verhoef D Milatovic (2004) ArticleTitleIn vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants Antimicrob Agents Chemother 48 1007–11 Occurrence Handle10.1128/AAC.48.3.1007-1011.2004 Occurrence Handle14982796

    Article  PubMed  Google Scholar 

  14. SS Richter DE Kealey CT Murray KP Heilmann SL Coffman GV Doern (2003) ArticleTitleThe in vitro activity of daptomycim against Staphylococcus aureus and Enterococcus species J Antimicrob Chemother 52 123–7 Occurrence Handle10.1093/jac/dkg288 Occurrence Handle12805265

    Article  PubMed  Google Scholar 

  15. PK Dandekar PR Tessier P Williams CH Nightingale DP Nicolau (2003) ArticleTitlePharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model J Antimicrob Chemother 52 405–11 Occurrence Handle10.1093/jac/dkg337 Occurrence Handle12917254

    Article  PubMed  Google Scholar 

  16. N Safdar D Andes WA Craig (2004) ArticleTitleIn vivo pharmacodynamic activity of daptomycin Antimicrob Agents Chemother 48 63–8 Occurrence Handle10.1128/AAC.48.1.63-68.2004 Occurrence Handle14693519

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robin Patel.

Additional information

Presented in part at the 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, 2003 and at the 44th ICAAC, Washington, DC, 2004

About this article

Cite this article

Piper, K., Steckelberg, J. & Patel, R. In vitro activity of daptomycin against clinical isolates ofGram-positive bacteria. J Infect Chemother 11, 207–209 (2005). https://doi.org/10.1007/s10156-005-0395-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-005-0395-x

Key words

  • Daptomycin
  • Gram-positive bacteria
  • Antimicrobial resistance
  • Endocarditis
  • Enterococci
  • Streptococci